SEMAGLUTIDE

SEMAGLUTIDE INFORMATION (GLP-1)

BENEFITS

• Decreased appetite and reduced cravings
• Significant weight loss
• Clinical trials demonstrated up to 15% weight loss depending on dosage
• Compounded formulas may include additional medications to minimize nausea
• Convenient once-weekly injections
• The program can be repeated as needed for continued weight management

COMMON SIDE EFFECTS

• Nausea
• Constipation
• Indigestion

RISK OF THYROID C-CELL TUMORS

Semaglutide should not be taken if you or a family member has been diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or medullary thyroid cancer.

INFORMATION

Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist that works by targeting areas of the brain responsible for regulating appetite and food intake. In clinical trials, participants experienced up to 15% weight loss compared to placebo groups, making it an effective option for weight management.